Enzyme Offers Support for Teams Dealing with COVID-19

A word on COVID-19 from the Enzyme Team


Dear Enzyme Friends & Customers,


As the world reacts to the universal and profound nature of COVID-19, the Enzyme team wants to offer our support to those on the frontlines trying to tackle the problem, and those elsewhere in the healthcare industry that are trying to deal with keeping their businesses running and their products shipping.


Stability is part of our mission to our customers. Recent events have tested our emotions but not our operations, as we have been a remote-first organization for over a year. Our teammates who need personal accommodations are taking them, but on average things are status quo at Enzyme. And we are standing by to assist our customers in this uncertain time.


Aid for SARS-CoV-2/COVID-19 Related Products


We know that teams developing novel coronavirus diagnostic tests and respiratory support devices will have increased pressure to commercialize on aggressive timelines. Enzyme has helped a number of FDA-regulated in vitro diagnostics (IVD) and medical devices get to market. 


In the United States, we’ve been slow to respond due to regulatory uncertainty surrounding Lab Developed Tests (LDTs), and accuracy concerns regarding the CDC-developed coronavirus diagnostic test. The US is now aligned on a framework, but we are very much behind-the-curve and scrambling to meet the immense demand for diagnostic tests, their component parts (such as reagents and nasal swabs), and treatment products.


In light of these challenges, we want to support companies developing solutions aimed at the diagnosis or treatment of the novel coronavirus SARS-CoV-2 and its related disease COVID-19. 


We are offering:

  • Free consulting session regarding Emergency Use Authorization (EUA) filings with FDA
  • Free onboarding and 2* months of free access** to Enzyme’s cloud-based electronic Quality Management System (eQMS) platform
  • Free access to the Enzyme Community with educational material and regulatory how-tos

* And we’ll increase our free access period if the crisis persists

** For new Enzyme customers



Aid for Teams Going Remote


If you are an existing biopharma or medical device company with a paper-based QMS, you may be wondering how to continue operations when the team is no longer on-site. Enzyme is here to help you. Though it might seem like everyone is focusing on coronavirus-related products to the exclusion of everything else, we realize the importance of ensuring that every other part of our healthcare system continues to function while we as a society align behind solving the threat at hand.


We are offering:

  • Free onboarding and 2 months of free access to Enzyme’s cloud-based electronic Quality Management System (eQMS) platform
  • Free access to the Enzyme Community with educational material and regulatory how-tos
  • Free weekly remote working best practice webinars


Our cloud-based eQMS supports social distancing efforts by ensuring all records are in-sync and digitally accessible in ways paper-based systems cannot.


Note: Such companies that are specifically adjusting to a remote work eQMS environment may be prioritized behind customers who are directly addressing the COVID-19 crisis.


Please contact info@enzyme.com for more information.


https://www.enzyme.com/courses/intro-to-qms

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Get more Enzyme in your inbox
Start with Enzyme today
info@enzyme.com or

Enzyme Offers Support for Teams Dealing with COVID-19

A word on COVID-19 from the Enzyme Team


Dear Enzyme Friends & Customers,


As the world reacts to the universal and profound nature of COVID-19, the Enzyme team wants to offer our support to those on the frontlines trying to tackle the problem, and those elsewhere in the healthcare industry that are trying to deal with keeping their businesses running and their products shipping.


Stability is part of our mission to our customers. Recent events have tested our emotions but not our operations, as we have been a remote-first organization for over a year. Our teammates who need personal accommodations are taking them, but on average things are status quo at Enzyme. And we are standing by to assist our customers in this uncertain time.


Aid for SARS-CoV-2/COVID-19 Related Products


We know that teams developing novel coronavirus diagnostic tests and respiratory support devices will have increased pressure to commercialize on aggressive timelines. Enzyme has helped a number of FDA-regulated in vitro diagnostics (IVD) and medical devices get to market. 


In the United States, we’ve been slow to respond due to regulatory uncertainty surrounding Lab Developed Tests (LDTs), and accuracy concerns regarding the CDC-developed coronavirus diagnostic test. The US is now aligned on a framework, but we are very much behind-the-curve and scrambling to meet the immense demand for diagnostic tests, their component parts (such as reagents and nasal swabs), and treatment products.


In light of these challenges, we want to support companies developing solutions aimed at the diagnosis or treatment of the novel coronavirus SARS-CoV-2 and its related disease COVID-19. 


We are offering:

  • Free consulting session regarding Emergency Use Authorization (EUA) filings with FDA
  • Free onboarding and 2* months of free access** to Enzyme’s cloud-based electronic Quality Management System (eQMS) platform
  • Free access to the Enzyme Community with educational material and regulatory how-tos

* And we’ll increase our free access period if the crisis persists

** For new Enzyme customers



Aid for Teams Going Remote


If you are an existing biopharma or medical device company with a paper-based QMS, you may be wondering how to continue operations when the team is no longer on-site. Enzyme is here to help you. Though it might seem like everyone is focusing on coronavirus-related products to the exclusion of everything else, we realize the importance of ensuring that every other part of our healthcare system continues to function while we as a society align behind solving the threat at hand.


We are offering:

  • Free onboarding and 2 months of free access to Enzyme’s cloud-based electronic Quality Management System (eQMS) platform
  • Free access to the Enzyme Community with educational material and regulatory how-tos
  • Free weekly remote working best practice webinars


Our cloud-based eQMS supports social distancing efforts by ensuring all records are in-sync and digitally accessible in ways paper-based systems cannot.


Note: Such companies that are specifically adjusting to a remote work eQMS environment may be prioritized behind customers who are directly addressing the COVID-19 crisis.


Please contact info@enzyme.com for more information.


https://www.enzyme.com/courses/intro-to-qms

Get more of Enzyme

Sign up for the latest updates in your inbox

Enzyme Blog

Automating life science regulatory and compliance

Making MDSAP Work for You
Jul 1, 2020
9
min read
The Single Device Audit: Great Hopes Still Unfulfilled
Jun 24, 2020
8
min read
Management System Status for ISO 13485 Complicates FDA Adoption
Jun 18, 2020
9
min read
Suspended Animation; U.S. LDT Regulation Behind EU
Jun 12, 2020
9
min read
Leftovers: Top Five Unfinished FDA Draft Guidances from 2019
Jun 7, 2020
8
min read
ISO 13485 and Part 820: Delays and Opportunities
May 29, 2020
8
min read
Best Practices for Handling Customer Complaints Post-Market
Mar 23, 2020
5
min read
Enzyme Offers Support for Teams Dealing with COVID-19
Mar 19, 2020
5
min read
How the Medical Device Sector Can Support Innovation Methods for Developing Digital Health Products
Mar 16, 2020
7
min read
A Guide to Navigating FDA Device Risk Classifications for New Products
Feb 21, 2020
5
min read
What Digital Health companies can expect from the FDA in 2020
Oct 17, 2019
2
min read
Expert Interview: Clinical Trial Planning for Startups with Boulder Clinical Science
Oct 15, 2019
5
min read
2019 RAPS Regulatory Convergence #2019RAPS
Sep 19, 2019
1
min read
Farewell, Dr. Gottlieb, you will be missed
Mar 7, 2019
3
min read
Creating A Culture Of Quality
Feb 19, 2019
3
min read
Our top conference picks for SaMD companies
Jan 25, 2019
3
min read
FDA Pre-Cert v1.0 Explained: 2019 and the Promises of Years to Come
Jan 9, 2019
7
min read
Ready to level up? Inquire about certification.
info@enzyme.com or

Ready to do more?